Official ESCRS | European Society of Cataract & Refractive Surgeons

 

Posters

Search Title by author or title

Combined method of myopic anisometropia correction

Poster Details

First Author: M.Shanturova RUSSIA

Co Author(s):    T. Iureva   E. Makarova                 

Abstract Details

Purpose:

To study the possibility of using different methods of surgical correction of myopic anisometropy associated with amblyopia and astigmatism in patients in fellow eyes.

Setting:

Irkutsk Branch of S. Fyodorov Eye Microsurgery Federal State Institution.

Methods:

A comparative analysis of the initial and postoperative status of 5 patients (10 eyes) who successively underwent surgical correction of myopic anisometropy in fellow eyes using laser refractive or intraocular surgery, depending on the degree of myopia was performed. In the eyes with high myopia and astigmatism complicated by amblyopia of various degrees, extraction of transparent lens by phacoemulsification with implantation of multifocal-toric IOL (LISA toric (Carl Zeiss) was performed. FemtoLasik was used in fellow eyes with less degree of myopia.

Results:

1 day after the operation all patients showed a significant, almost 10 times higher uncorrected visual acuity (UCVA). In all cases, planned refractive result was achieved (±0.5±0.25 DPTR, cylindrical equivalent of -0.3±0.15 DPTR). Result was persistent throughout the follow up period (from 6 months to 1 year). With time in some patients a moderate increase of UCVA on the amblyopic eye was noted. Evaluation of subjective satisfaction by the quality of vision using the questionnaire VFQ 14 was 4.8±0.1 points. There were no complaints common for binocular dysfunction. Additional spectacle correction was not required in any case.

Conclusions:

Thus, the use of various methods of surgical correction of myopic anisometropia in fellow eyes does not have a negative impact on the processes of neuroadaptation to new conditions of visual perception and provides not only a high functional result, but also a satisfactory quality of vision.

Financial Disclosure:

None

Back to Poster listing